Detalles de la búsqueda
1.
Atractylenolide-I Protects Human SH-SY5Y Cells from 1-Methyl-4-Phenylpyridinium-Induced Apoptotic Cell Death.
Int J Mol Sci
; 18(5)2017 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28481321
2.
A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways.
Acta Pharmacol Sin
; 37(3): 334-43, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26838070
3.
Toxin-Induced Experimental Models of Learning and Memory Impairment.
Int J Mol Sci
; 17(9)2016 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27598124
4.
Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases.
Nat Prod Rep
; 31(1): 109-39, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24292194
5.
EOP, a newly synthesized ethyl pyruvate derivative, attenuates the production of inflammatory mediators via p38, ERK and NF-κB pathways in lipopolysaccharide-activated BV-2 microglial cells.
Molecules
; 19(12): 19361-75, 2014 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-25429561
6.
Anti-neuroinflammatory activity of a novel cannabinoid derivative by inhibiting the NF-κB signaling pathway in lipopolysaccharide-induced BV-2 microglial cells.
J Pharmacol Sci
; 121(2): 119-30, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23370667
7.
Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease.
Mediators Inflamm
; 2013: 952375, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23935251
8.
Traditional Korean East Asian medicines and herbal formulations for cognitive impairment.
Molecules
; 18(12): 14670-93, 2013 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-24287997
9.
Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease.
Int J Mol Sci
; 13(8): 10608-10629, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22949883
10.
The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism.
Int J Mol Sci
; 13(8): 10478-10504, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22949875
11.
Promising therapeutics with natural bioactive compounds for improving learning and memory--a review of randomized trials.
Molecules
; 17(9): 10503-39, 2012 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-22945029
12.
Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease.
Molecules
; 17(10): 11391-420, 2012 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-23014498
13.
The role of bioactive compounds on the promotion of neurite outgrowth.
Molecules
; 17(6): 6728-53, 2012 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-22664464
14.
Emerging preclinical pharmacological targets for Parkinson's disease.
Oncotarget
; 7(20): 29835-63, 2016 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26988916
15.
Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection.
Mol Neurodegener
; 10: 17, 2015 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-25888232
16.
Anti-neuroinflammatory effects of DPTP, a novel synthetic clovamide derivative in in vitro and in vivo model of neuroinflammation.
Brain Res Bull
; 112: 25-34, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25596423
17.
A novel synthetic HTB derivative, BECT inhibits lipopolysaccharide-mediated inflammatory response by suppressing the p38 MAPK/JNK and NF-κB activation pathways.
Pharmacol Rep
; 66(3): 471-9, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24905526
18.
ß-Asarone (cis-2,4,5-trimethoxy-1-allyl phenyl), attenuates pro-inflammatory mediators by inhibiting NF-κB signaling and the JNK pathway in LPS activated BV-2 microglia cells.
Food Chem Toxicol
; 72: 265-72, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25066769
19.
Strategic selection of neuroinflammatory models in Parkinson's disease: evidence from experimental studies.
CNS Neurol Disord Drug Targets
; 12(5): 680-97, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23469840
20.
Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model.
Evid Based Complement Alternat Med
; 2013: 514095, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23533492